Eugene Schneider, EVP, Chf Clinical Develop Ofcr at IONIS PHARMACEUTICALS INC (IONS), sold 11,624 shares at $70.97 ($825K) on 2026-03-19, disclosed to the SEC on 2026-03-23.
Scheduled sale ($825k) by EVP, Chf Clinical Develop Ofcr under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.97 | 5,812 | $412K | 50.0% |
| 2 | $70.97 | 5,812 | $412K | 50.0% |
| Total | $70.97 avg | 11,624 | $825K | 100% |
| Filing → |
| IONS | SELL | 2026-01-20 | $703K | — | Filing → |
| IONS | SELL | 2025-09-04 | $2.4M | — | Filing → |
| IONS | SELL | 2025-08-05 | $817K | — | Filing → |